SCHEMBL9613956

SCHEMBL9613956

Cc1ccc(OCCCl)c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.48
▸ IDO1 P14902 1/20 0.43
▸ GPR84 Q9NQS5 4/20 0.43
▸ KDM4E B2RXH2 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ MEN1 O00255 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CYP2A6 P11509 1/20 0.38
▸ HTR1B P28222 4/20 0.38
▸ HTR1D P28221 1/20 0.38
▸ CNR1 P21554 2/20 0.37
▸ CNR2 P34972 2/20 0.37
▸ MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12604032 0.88 IDO1 (0.52) IDO1GPR84KDM4ESMN1; SMN2MEN1
SCHEMBL12604015 0.83 IDO1 (0.50) CYP1A2IDO1GPR84KDM4ESMN1; SMN2
SCHEMBL25638485 0.83 CNR1 (0.51) CYP1A2IDO1KDM4ESMN1; SMN2MEN1
SCHEMBL16065361 0.81 CYP1A2 (0.48) CYP1A2IDO1GPR84KDM4ESMN1; SMN2
SCHEMBL14396287 0.81 IDO1 (0.66) CYP1A2IDO1KDM4ESMN1; SMN2MEN1
SCHEMBL12460239 0.81 CNR1 (0.52) CYP1A2IDO1KDM4EMEN1ALDH1A1
SCHEMBL6715331 0.79 CNR1 (0.55) CYP1A2MEN1KMT2ALMNATDP1
SCHEMBL18949728 0.79 HTR1B (0.63) CYP1A2KDM4ESMN1; SMN2MEN1ALDH1A1
SCHEMBL8229480 0.79 CYP1A2 (0.54) CYP1A2KDM4ESMN1; SMN2MEN1ALDH1A1
SCHEMBL2023982 0.78 IDO1 (0.71) IDO1GPR84KDM4ESMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5135947-A Treatment of depression, eating disorders, and alcoholism ELI LILLY AND COMPANY (US) 1992-08-04 — — US disclosed
EP-0288188-B1 1-PHENYL-3-NAPHTHALENYLOXY-PROPANAMINES ELI LILLY AND COMPANY (US) 1991-10-16 — — EP disclosed
EP-0288188-A1 1-Phenyl-3-naphthalenyloxy-propanamines ELI LILLY AND COMPANY (US) 1988-10-26 — — EP disclosed
Send feedback